Research Papers

25 of 1221 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials.
Smith K; Hegazy K; Cai MR; McKnight I; Rousculp MD; Alves K.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.
Salmanton-García J; Wipfler P; Valle-Simón P; Merakou C; Kopsidas I; Bethe U; Steinbach A; Spivak O; Součková L; Mendonça MA; Koniordou M; Hellemans M; Frías-Iniesta J; Davis RJ; Barta I; Azzini AM; Askling HH; Argyropoulos CD; Álvarez-Barco E; Akova M; Bonten MMJ; Cohen-Kandli M; Cox RJ; Flisiak R; Husa P; Jancoriene L; Koscalova A; Launay O; Lundgren J; Mallon P; Marques L; Nauclér P; Ochando J; Pana ZD; Tacconelli E; Tóth K; Trelle S; van Damme P; Zaoutis TE; Zeitlinger M; Albus K; Stewart FA; Hofstraat SHI; Bruijning-Verhagen P; Cornely OA; VACCELERATE Consortium. Electronic address: trialsites@vaccelerate.eu.
Vaccine (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
COVID-19 vaccine decision-making among pregnant and lactating women in Bangladesh.
Limaye RJ; Singh P; Paul A; Fesshaye B; Lee C; Zavala E; Wade S; Ali H; Rahman H; Akter S; Karron R; Jahan Siddiqua T.
Vaccine (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Monkeypox, smallpox, FDA, and accelerated approval of vaccines - A regulatory perspective.
Sun WMD.
Vaccine (Unknown)
Published: 2023
2/6 Transparent
Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previous…
Kuriyama K; Murakami K; Masuda T; Sugiura K; Sakui S; Schuring RP; Mori M.
Vaccine (Unknown)
Published: 2023
5/6 Transparent
Data Registered Funding Declared
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future.
Black SB; Chandler RE; Edwards KM; Sturkenboom MCJM.
Vaccine (Unknown)
Published: 2023
2/6 Transparent
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associat…
Roy Á; Polazzi S; Ploin D; Gillet Y; Javouhey E; Lina B; VRS study group in Lyon; Myard-Dury AF; Couray-Targe S; Duclos A; Casalegno JS.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
COVID-19 vaccination rates among adolescents (12-17 years) by immigrant background and sociodemographic factors: A nati…
Hussaini L; Labberton AS; Winje BA; Kraft KB; Kjøllesdal MKR; Gleditsch RN; Godøy AA.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Advances in intranasal vaccine delivery: A promising non-invasive route of immunization.
Kehagia E; Papakyriakopoulou P; Valsami G.
Vaccine (Unknown)
Published: 2023
2/6 Transparent
Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A pro…
Ku JH; Sy LS; Qian L; Ackerson BK; Luo Y; Tubert JE; Lee GS; Florea A; Bruxvoort KJ; Talarico CA; Qiu S; Tian Y; Tseng HF.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico.
Rodriguez DM; Major CG; Sánchez-González L; Jones E; Delorey MJ; Alonso C; Rivera-Amill V; Paz-Bailey G; Adams LE.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Identifying gaps in vaccination perception after mandating the COVID-19 vaccine in Saudi Arabia.
Alsuhebany N; Alowais SA; Aldairem A; Almohareb SN; Bin Saleh K; Kahtani KM; Alnashwan LI; Alay SM; Alamri MG; Alhathlol GK; Asiri I.
Vaccine (Unknown)
Published: 2023
3/6 Transparent
Data
Effectiveness of the COVID-19 vaccines on preventing symptomatic SARS-CoV-2 infections and hospitalizations in Southwes…
Lefferts B; Bruden D; Plumb ID; Hodges E; Bates E; January G; Bruce MG.
Vaccine (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
COVID-19 vaccine deliberation in individuals directly impacted by incarceration.
Kim C; Aminawung JA; Brinkley-Rubinstein L; Wang EA; Puglisi LB.
Vaccine (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placeb…
Marchese AM; Zhou X; Kinol J; Underwood E; Woo W; McGarry A; Beyhaghi H; Áñez G; Toback S; Dunkle LM.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home resident…
Nugent C; Abul Y; White EM; Shehadeh F; Kaczynski M; Oscar Felix L; Ganesan N; Oyebanji OA; Vishnepolskiy I; Didion EM; Paxitzis A; Sheehan ML; Chan PA; Pfeifer WM; Dickerson E; Kamojjala S; Wilson BM; Mylonakis E; King CL; Balazs AB; Canaday DH; Gravenstein S.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Learning from five bad arguments against mandatory vaccination.
Smith MJ; Emanuel EJ.
Vaccine (Unknown)
Published: 2023
2/6 Transparent
COVID-19 vaccine distribution: A high reliability organization approach.
Houtsma C; Raines AM; Reggio A; Rushing LK; Harding E; Payton E; Martin-Klinger C.
Vaccine (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies.
Roper RL; Garzino-Demo A; Del Rio C; Bréchot C; Gallo R; Hall W; Esparza J; Reitz M; Schinazi RF; Parrington M; Tartaglia J; Koopmans M; Osorio J; Nitsche A; Huan TB; LeDuc J; Gessain A; Weaver S; Mahalingam S; Abimiku A; Vahlne A; Segales J; Wang L; Isaacs SN; Osterhaus A; Scheuermann RH; McFadden G.
Vaccine (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontari…
Leigh Hobbs J; Paul LA; Buchan SA; Harris T; Wilson SE.
Vaccine (Unknown)
Published: 2023
2/6 Transparent
Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse…
Freitag TL; Fagerlund R; Karam NL; Leppänen VM; Ugurlu H; Kant R; Mäkinen P; Tawfek A; Jha SK; Strandin T; Leskinen K; Hepojoki J; Kesti T; Kareinen L; Kuivanen S; Koivulehto E; Sormunen A; Laidinen S; Khattab A; Saavalainen P; Meri S; Kipar A; Sironen T; Vapalahti O; Alitalo K; Ylä-Herttuala S; Saksela K.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2…
Braeye T; Catteau L; Brondeel R; van Loenhout JAF; Proesmans K; Cornelissen L; Van Oyen H; Stouten V; Hubin P; Billuart M; Djiena A; Mahieu R; Hammami N; Van Cauteren D; Wyndham-Thomas C.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Public discourse and debate about vaccines in the midst of the covid-19 pandemic: A qualitative content analysis of Twi…
Prada E; Langbecker A; Catalan-Matamoros D.
Vaccine (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-C…
Estephan L; Lin YC; Lin YT; Chen YH; Pan SC; Hsieh SM; Torkehagen PF; Weng YJ; Cheng HY; Estrada JA; Waits A; Chen C; Lien CE.
Vaccine (Unknown)
Published: 2023
5/6 Transparent
Data Registered Funding Declared
Factors associated with COVID-19 vaccination during June-October 2021: A multi-site prospective study.
Datar RS; Fette LM; Hinkelman AN; Hammershaimb EA; Friedman-Klabanoff DJ; Mongraw-Chaffin M; Weintraub WS; Ahmed N; Gibbs MA; Runyon MS; Plumb ID; Thompson W; Saydah S; Edelstein SL; Berry AA; COVID-19 Community Research Partnership.
Vaccine (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared